[ad_1]
Published in:
In a step that will enable the launch of a large-scale vaccination campaign, the Indian Medicines Regulatory Authority on Sunday authorized the two vaccines against the Covid-19 epidemic, namely the AstraZeneca-Oxford vaccine and another vaccine. local developed by the Indian pharmaceutical company Bharat Biotech. “These vaccines are 100 percent safe,” said the General Supervisor of Medications, explaining that observed side effects, such as “mild fever, pain, and allergies, are common to all vaccines.” The number of coronavirus infections in India has exceeded 10 million and 150,000 people have so far died from the disease.
The Comptroller General of Medicines explained in India FG. Sumani said during a press conference that her country’s Medicines Regulatory Authority authorized, on Sunday, two vaccines against the Covid-19 epidemic, one of which is the vaccine developed by a group. AstraZeneca With the University of Oxford, the second was developed by the Indian pharmaceutical company Bharat Biotech.
Somani said the two vaccines “have been approved for limited use in emergencies,” in a decision that would allow the launch of an intensive vaccination campaign in India. Prime Minister Narendra Modi said that this emergency approval constitutes a “decisive turning point to strengthen the fighting spirit” and “accelerate the path towards eliminating the Covid-19 epidemic.”
India, with a population of 1.3 billion, has recorded more than 10.3 million infections and nearly 150,000 deaths so far from the virus.
However, the rate of new infections has dropped significantly compared to what it was in September, when more than 90,000 new infections were recorded daily. This approval is supposed to allow the launch of a large-scale vaccination campaign.
It was implemented Simulation exercises For the nationwide vaccination campaign, 96,000 health workers were trained to administer the vaccine.
Somani told the media that the Drug Regulatory Authority “would not have given its approval (for the vaccines) if there were safety concerns.”
“These vaccines are 100 percent safe,” he added, explaining that observed side effects, such as “mild fever, pain, and allergies, are common to all vaccines.”
The Serum Institute of India, the world’s largest vaccine producer, said it manufactures between 50 and 60 million doses of the AstraZeneca vaccine each month.
The institute’s executive director, Adar Poonawala, said after announcing the approval that the vaccine would be “ready for distribution in the next few weeks.”
France 24 / AFP
